Riverpark Capital Management’s Exact Sciences EXAS Stock Holding History
Bought
Maintained
Sold
Other funds holding EXAS
AIM
NAMA
Riverpark Capital Management's EXAS Position: Q2 2022 in Review
Riverpark Capital Management sold out of Exact Sciences (EXAS) in Q2 2022, closing a stake of 100,692 shares — an estimated $7.04M sold.
Riverpark Capital Management first reported a position in EXAS in Q2 2018 and held it in 16 quarters. The position peaked at $15.1M in Q3 2018. 501 funds tracked by Wall St. Rank hold EXAS as of Q2 2022.
- Riverpark Capital Management reported no remaining Exact Sciences position as of Q2 2022 after selling out during the quarter.
- Riverpark Capital Management sold 100,692 Exact Sciences shares in Q2 2022, an estimated $7.04M.
- Riverpark Capital Management first reported a position in Exact Sciences in Q2 2018 and held it in 16 quarters.
- Riverpark Capital Management's Exact Sciences position peaked at $15.1M in Q3 2018.
- 501 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2022.
Based on Riverpark Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.